{"transactions":[{"id":737983,"issuer":{"id":6169,"kind":"organization","name":"Tonix Pharmaceuticals Holding Corp.","symbol":"TNXP"},"owners":[{"id":38223,"kind":"person","name":"Taylor Carolyn E.","position":1,"cik":"0001875324","reported_name":"Taylor Carolyn E.","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock, $0.001 par value","published_at":"2026-06-15T11:00:12.000Z","date":"2026-06-12","kind":"purchase","planned":false,"acquired":true,"shares":1415,"price":10.55,"value":14928.25,"ownership":{"direct":true},"balance_after":1833,"source":{"system":"sec-edgar","filing":"0001493152-26-028608","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1875324/000149315226028608/ownership.xml","form_type":"4"}},{"id":779394,"issuer":{"id":6169,"kind":"organization","name":"Tonix Pharmaceuticals Holding Corp.","symbol":"TNXP"},"owners":[{"id":38223,"kind":"person","name":"Taylor Carolyn E.","position":1,"cik":"0001875324","reported_name":"Taylor Carolyn E.","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option","published_at":"2026-05-14T21:41:51.000Z","date":"2026-05-12","kind":"grant","planned":false,"acquired":true,"shares":22700,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"The option was granted pursuant to the Issuer's 2026 Stock Incentive Plan, and vests on the earlier of the one year anniversary of the grant date and the Issuer's 2027 Annual Meeting of Stockholders."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The option was granted pursuant to the Issuer's 2026 Stock Incentive Plan, and vests on the earlier of the one year anniversary of the grant date and the Issuer's 2027 Annual Meeting of Stockholders."}],"balance_after":22700,"derivative":{"exercise_price":13.28,"exercise_date":"2027-05-12","expiration_date":"2036-05-12","underlying":"Common Stock","underlying_shares":22700},"source":{"system":"sec-edgar","filing":"0001999371-26-010747","document":"taylor-form4_051426.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1875324/000199937126010747/taylor-form4_051426.xml","form_type":"4"}},{"id":1059375,"issuer":{"id":6169,"kind":"organization","name":"Tonix Pharmaceuticals Holding Corp.","symbol":"TNXP"},"owners":[{"id":38223,"kind":"person","name":"Taylor Carolyn E.","position":1,"cik":"0001875324","reported_name":"Taylor Carolyn E.","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock, par value $0.001","published_at":"2025-08-21T21:22:56.000Z","date":"2025-08-21","kind":"purchase","planned":false,"acquired":true,"shares":418,"price":36.03,"value":15060.54,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"Represents the weighted average purchase price. Actual purchase prices ranged from $35.98 to $36.05."}],"balance_after":418,"source":{"system":"sec-edgar","filing":"0001999371-25-011836","document":"taylor-form4_082125.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1875324/000199937125011836/taylor-form4_082125.xml","form_type":"4"}},{"id":1147651,"issuer":{"id":6169,"kind":"organization","name":"Tonix Pharmaceuticals Holding Corp.","symbol":"TNXP"},"owners":[{"id":38223,"kind":"person","name":"Taylor Carolyn E.","position":1,"cik":"0001875324","reported_name":"Taylor Carolyn E.","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option","published_at":"2025-05-15T20:57:11.000Z","date":"2025-05-13","kind":"grant","planned":false,"acquired":true,"shares":10000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"The option was granted pursuant to the Issuer's Amended and Restated 2020 Stock Incentive Plan, as amended, and vests on the earlier of the one year anniversary of the grant date or the Issuer's 2026 Annual Meeting of Stockholders."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The option was granted pursuant to the Issuer's Amended and Restated 2020 Stock Incentive Plan, as amended, and vests on the earlier of the one year anniversary of the grant date or the Issuer's 2026 Annual Meeting of Stockholders."}],"balance_after":10000,"derivative":{"exercise_price":20.18,"exercise_date":"2026-05-13","expiration_date":"2035-05-13","underlying":"Common Stock","underlying_shares":10000},"source":{"system":"sec-edgar","filing":"0001999371-25-006250","document":"taylor-form4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1875324/000199937125006250/taylor-form4.xml","form_type":"4"}},{"id":1502216,"issuer":{"id":6169,"kind":"organization","name":"Tonix Pharmaceuticals Holding Corp.","symbol":"TNXP"},"owners":[{"id":38223,"kind":"person","name":"Taylor Carolyn E.","position":1,"cik":"0001875324","reported_name":"Taylor Carolyn E.","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option","published_at":"2024-05-24T21:10:36.000Z","date":"2024-05-23","kind":"grant","planned":false,"acquired":true,"shares":104621,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"The option was granted pursuant to the Issuer's Amended and Restated 2020 Stock Incentive Plan and vests on the earlier of the one year anniversary of the grant date or the Issuer's 2025 Annual Meeting of Stockholders."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The option was granted pursuant to the Issuer's Amended and Restated 2020 Stock Incentive Plan and vests on the earlier of the one year anniversary of the grant date or the Issuer's 2025 Annual Meeting of Stockholders."}],"balance_after":104621,"derivative":{"exercise_price":0.1745,"exercise_date":"2025-05-23","expiration_date":"2034-05-23","underlying":"Common Stock","underlying_shares":104621},"source":{"system":"sec-edgar","filing":"0001999371-24-006624","document":"taylor-form4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1875324/000199937124006624/taylor-form4.xml","form_type":"4"}},{"id":1898316,"issuer":{"id":6169,"kind":"organization","name":"Tonix Pharmaceuticals Holding Corp.","symbol":"TNXP"},"owners":[{"id":38223,"kind":"person","name":"Taylor Carolyn E.","position":1,"cik":"0001875324","reported_name":"Taylor Carolyn E.","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option","published_at":"2023-05-10T21:08:34.000Z","date":"2023-05-08","kind":"grant","planned":false,"acquired":true,"shares":60000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F2","text":"Does not reflect a 1-for-6.25 reverse stock split of the Issuer's common stock effective May 10, 2023."},{"field":"price","element":"transactionPricePerShare","label":"F1","text":"The option was granted pursuant to the Issuer's Amended and Restated 2020 Stock Incentive Plan and vests on the earlier of the one year anniversary of the grant date or the Issuer's 2024 Annual Meeting of Stockholders."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The option was granted pursuant to the Issuer's Amended and Restated 2020 Stock Incentive Plan and vests on the earlier of the one year anniversary of the grant date or the Issuer's 2024 Annual Meeting of Stockholders."},{"field":"derivative.underlying_shares","element":"underlyingSecurityShares","label":"F2","text":"Does not reflect a 1-for-6.25 reverse stock split of the Issuer's common stock effective May 10, 2023."}],"balance_after":60000,"derivative":{"exercise_price":0.509,"exercise_date":"2024-05-08","expiration_date":"2033-05-08","underlying":"Common Stock","underlying_shares":60000},"source":{"system":"sec-edgar","filing":"0001839882-23-012500","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1875324/000183988223012500/ownership.xml","form_type":"4"}},{"id":2274984,"issuer":{"id":6169,"kind":"organization","name":"Tonix Pharmaceuticals Holding Corp.","symbol":"TNXP"},"owners":[{"id":38223,"kind":"person","name":"Taylor Carolyn E.","position":1,"cik":"0001875324","reported_name":"Taylor Carolyn E.","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option","published_at":"2022-05-11T21:49:47.000Z","date":"2022-05-09","kind":"grant","acquired":true,"shares":2131500,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"The option was granted pursuant to the Issuer's Amended and Restated 2020 Stock Incentive Plan."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The option was granted pursuant to the Issuer's Amended and Restated 2020 Stock Incentive Plan."}],"balance_after":2131500,"derivative":{"exercise_price":0.132,"exercise_date":"2023-05-09","expiration_date":"2032-05-09","underlying":"Common Stock","underlying_shares":2131500},"source":{"system":"sec-edgar","filing":"0001387131-22-006019","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1875324/000138713122006019/ownership.xml","form_type":"4"}},{"id":2624081,"issuer":{"id":6169,"kind":"organization","name":"Tonix Pharmaceuticals Holding Corp.","symbol":"TNXP"},"owners":[{"id":38223,"kind":"person","name":"Taylor Carolyn E.","position":1,"cik":"0001875324","reported_name":"Taylor Carolyn E.","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option","published_at":"2021-07-28T01:46:47.000Z","date":"2021-07-16","kind":"grant","acquired":true,"shares":237437,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The option was granted pursuant to the Issuer's Amended and Restated 2020 Stock Incentive Plan and is exercisable on the Issuer's 2022 Annual Meeting of Stockholders."}],"balance_after":237437,"derivative":{"exercise_price":0.98,"expiration_date":"2031-07-16","underlying":"Common Stock","underlying_shares":237437},"source":{"system":"sec-edgar","filing":"0001387131-21-007670","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1875324/000138713121007670/ownership.xml","form_type":"4"}}]}